These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2243199)

  • 1. [Ganglioside as a potential immune modulator: selective CD4-modulation and inhibition of human immunodeficiency virus infection].
    Nakakuma H; Kawaguchi T; Takatsuki K
    Seikagaku; 1990 Aug; 62(8):1044-7. PubMed ID: 2243199
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycosphingolipids affect on the functional properties of human lymphocytes--in relation to HIV-infection of lymphocytes].
    Nakakuma H; Kawaguchi T; Takatsuki K
    Hum Cell; 1989 Mar; 2(1):45-50. PubMed ID: 2519203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human immunodeficiency virus infection of human lymphocytes by gangliosides.
    Nakakuma H; Kawaguchi T; Koito A; Hattori T; Kagimoto T; Takatsuki K
    Jpn J Cancer Res; 1989 Aug; 80(8):702-5. PubMed ID: 2511174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside-induced CD4 endocytosis occurs independent of serine phosphorylation and is accompanied by dissociation of P56lck.
    Repke H; Barber E; Ulbricht S; Buchner K; Hucho F; Kopp R; Scholz H; Rudd CE; Haseltine WA
    J Immunol; 1992 Oct; 149(8):2585-91. PubMed ID: 1401895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical residues of ganglioside molecules involved in interactions with lymphocyte surface targets leading to CD4 masking and inhibition of mitogenic proliferation.
    Grassi F; Lopalco L; Lanza P; Ciccomascolo F; Cazzola F; Di Martino A; Kirschner G; Callegaro L; Chieco-Bianchi L; Siccardi AG
    Eur J Immunol; 1990 Jan; 20(1):145-50. PubMed ID: 1968389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the CD4 molecule: surface expression and function.
    Morrison WJ; Offner H; Vandenbark AA
    J Neurosci Res; 1994 May; 38(1):1-5. PubMed ID: 8057386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD4: another therapeutic option in HIV infection.
    Lancet; 1990 May; 335(8698):1128-30. PubMed ID: 1971867
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant CD4-IgE, a novel hybrid molecule, inducing basophils to respond to human immunodeficiency virus (HIV) and HIV-infected target cells.
    Krauss S; Kufer P; Federle C; Tabaszewski P; Weiss E; Rieber EP; Riethmüller G
    Eur J Immunol; 1995 Jan; 25(1):192-9. PubMed ID: 7531144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.
    Kinter AL; Hennessey M; Bell A; Kern S; Lin Y; Daucher M; Planta M; McGlaughlin M; Jackson R; Ziegler SF; Fauci AS
    J Exp Med; 2004 Aug; 200(3):331-43. PubMed ID: 15280419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interaction between HIV and CD4 antigen and application of CD4 derivatives to AIDS therapy].
    Mizukami T
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(3):225-35. PubMed ID: 1691857
    [No Abstract]   [Full Text] [Related]  

  • 11. Gangliosides induce selective modulation of CD4 from helper T lymphocytes.
    Offner H; Thieme T; Vandenbark AA
    J Immunol; 1987 Nov; 139(10):3295-305. PubMed ID: 2960731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganglioside structure, function and biomedical potential.
    Adv Exp Med Biol; 1984; 174():3-628. PubMed ID: 6741735
    [No Abstract]   [Full Text] [Related]  

  • 13. A highly selected panel of anti-CD4 antibodies fails to induce anti-idiotypic antisera mediating human immunodeficiency virus neutralization.
    Healey DG; Dianda L; Buck D; Schroeder K; Truneh A; Sattentau QJ; Beverley PC
    Eur J Immunol; 1991 Jun; 21(6):1491-8. PubMed ID: 1710569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ganglioside enhancement of neuronal differentiation, plasticity, and repair.
    Gorio A
    CRC Crit Rev Clin Neurobiol; 1986; 2(3):241-96. PubMed ID: 3536311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 immunoadhesins in anti-HIV therapy: new developments.
    Chamow SM; Duliege AM; Ammann A; Kahn JO; Allen JD; Eichberg JW; Byrn RA; Capon DJ; Ward RH; Ashkenazi A
    Int J Cancer Suppl; 1992; 7():69-72. PubMed ID: 1428410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possible use of recombinant CD4 in the therapy of AIDS].
    Praglia C
    Minerva Pediatr; 1990; 42(1-2):49-51. PubMed ID: 2110615
    [No Abstract]   [Full Text] [Related]  

  • 17. Biologic and immunomodulating factors in the treatment of pediatric acquired immunodeficiency syndrome.
    Ammann AJ
    Pediatr Infect Dis J; 1990 Dec; 9(12):894-904. PubMed ID: 1703652
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of intensification of an HIV viral infection with monoclonal antibodies].
    Ignat'eva GA; Sidorovich IG; Nesterchuk SL; Barinskiĭ IF
    Dokl Akad Nauk SSSR; 1989; 306(5):1272-5. PubMed ID: 2791870
    [No Abstract]   [Full Text] [Related]  

  • 19. Janusin: new molecular design for bispecific reagents.
    Traunecker A; Lanzavecchia A; Karjalainen K
    Int J Cancer Suppl; 1992; 7():51-2. PubMed ID: 1428404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
    Imlach S; McBreen S; Shirafuji T; Leen C; Bell JE; Simmonds P
    J Virol; 2001 Dec; 75(23):11555-64. PubMed ID: 11689637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.